Company Filing History:
1 out of 81 
1 out of 156 Years Active: 2007
Title: Inventor Jaak Janssens: Pioneering hCG Therapy for Breast Cancer
Introduction: Jaak Janssens, a notable inventor from Hasselt, Belgium, has significantly contributed to the field of cancer therapy with his innovative approach to treating breast cancer. With a focus on utilizing human Chorionic Gonadotropin (hCG), his pioneering work stands at the intersection of medical treatment and innovative research.
Latest Patents: Jaak Janssens holds a patent for his invention titled "hCG therapy for the treatment of breast cancer." This groundbreaking treatment targets mammary tumors, including clinically manifest and metastatic breast cancer. The invention proposes the administration of hCG in combination with an antiestrogen and/or Type I Interferon, marking a notable advancement in cancer therapy.
Career Highlights: Throughout his career, Jaak Janssens has been associated with esteemed institutions that embody the spirit of innovation in medical research. Notably, he has worked at the Fox Chase Cancer Center, a leading organization in oncology research, and at Applied Research Systems Ars Holding N.V., where he applied his expertise to further develop treatment methodologies for cancer.
Collaborations: Jaak has collaborated with notable colleagues, including Irma H. Russo and Jose Russo. Their combined efforts reflect a commitment to furthering the understanding and treatment of breast cancer, contributing to advancements in cancer research and patient care.
Conclusion: As an inventor, Jaak Janssens has made significant strides in cancer therapy through his innovative hCG treatment for breast cancer. His dedication to research and collaboration showcases the importance of innovation in overcoming complex medical challenges, ultimately aiming to improve the lives of those affected by breast cancer.